COPD

The Pharmacy Times® Chronic Obstructive Pulmonary Disease (COPD) Disease Resource Center is a comprehensive resource for clinical news and expert insights on a group of diseases that cause airflow blockage and breathing-related problems, including emphysema and chronic bronchitis.

Daily Medication Pearl: Budesonide, Glycopyrrolate, and Formoterol Fumarate (Breztri)

April 12, 2022

Article

Breztri is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease.

Optimizing Care for Orphan Diseases With Pulmonary Issues During COVID-19 Pandemic

April 05, 2022

Article

The value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.

FDA Approves Symbicort Generic to Treat Asthma and COPD

March 17, 2022

Article

Agency hopes green light for complex drug device combination improves competition and access more affordable medications.

Daily Medication Pearl: Fluticasone/Salmeterol (Wixela)

January 10, 2022

Article

Wixela Inhub is indicated for the treatment of asthma in patients 4 years of age and older and maintenance treatment of patients with chronic obstructive pulmonary disease.

Daily Medication Pearl: Fluticasone Furoate and Vilanterol (Breo Ellipta)

January 07, 2022

Article

Breo Ellipta is indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

Daily Medication Pearl: Advair Diskus (Fluticasone and Salmeterol)

January 03, 2022

Article

Advair Diskus is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease.

Daily Medication Pearl: Bevespi (Glycopyrrolate/Formoterol)

December 20, 2021

Article

Bevespi is indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.

COPD Awareness Month: Pharmacists’ Role in Helping Patients Breathe Better

November 26, 2021

Article

Pharmacists have the potential to make a positive impact by screening patients, providing counseling, encouraging beneficial interventions, and helping tailor patient regimens based on personalized needs.

Study: Lack of Green, Blue Spaces in Urban Communities Negatively Impacts Quality of Life for Those With COPD

September 03, 2021

Article

Study shows the benefit of green and blue spaces for individuals with COPD living in urban communities.

Phase 2 Clinical Trial to Assess Efficacy of Breathing Exercise for Patients With Obstructive Sleep Apnea

September 02, 2021

Article

Inspiratory muscle training was originally devised to be used by athletes and individuals with breathing problems such as chronic obstructive pulmonary disease, asthma, and bronchitis.